All articles by GlobalData Healthcare

  1. Intercept’s Ocaliva access in NASH likely to be hit by payers’ biopsy requirements

    Intercept Pharmaceuticals should brace for payers requiring liver biopsies before clinicians are able to access Ocaliva (obeticholic acid) for nonalcoholic…
    Read More…

    17 Jan
  2. How significant is a novel route of administration for dry eye syndrome?

    Although treatments for dry eye syndrome (DES) have been well-established, lack of efficacy in their modes of action (MOAs) and…
    Read More…

    17 Jan
  3. Chronic diseases to keep an eye on in 2020 and beyond

    Epidemiological trends in the last decade have shown a significant increase in the burden of chronic illnesses globally, such as…
    Read More…

    17 Jan
  4. Alexion bets on ALS with pivotal phase III study for its future blockbuster ultomiris

    This quarter, Alexion Pharmaceuticals is set to launch a pivotal Phase III study of Ultomiris (ravulizumab) in amyotrophic lateral sclerosis…
    Read More…

    16 Jan
  5. Assessing recent approvals in bladder cancer

    On December 18 2019, the FDA granted accelerated approval for Seattle Genetic/Astellas Pharmaceutical’s Padcev (enfortumab vedotin-ejfv). Merck and Co’s Keytruda…
    Read More…

    16 Jan
  6. Regulatory review of the first ever gene therapy for haemophilia to start in January 2020

    In November 2019, BioMarin, a biotechnology company specialising in developing therapies for rare diseases driven by genetic causes, submitted a…
    Read More…

    14 Jan
  7. Could photobiomodulation be a breakthrough for Alzheimer’s disease?

    A Canadian biotechnology company leader in brain photobiomodulation (PBM) technology, Vielight, has developed a new headset device that could be…
    Read More…

    10 Jan
  8. Using AI to successfully predict risk of breast cancer

    Predicting future health outcomes for patients at an individual level will allow physicians to deliver care more quickly to those…
    Read More…

    10 Jan
  9. Twitter round-up: Neurology tweets – David Perlmutter’s tweet on meditation most popular in December 2019

    Top tweets on neurology in December 2019 1. David Perlmutter’s tweet on meditation David Perlmutter, a neurologist, tweeted on the…
    Read More…

    10 Jan
  10. Maintenance treatment positioned to become standard of care in acute myeloid leukemia

    Following the report of a successful clinical trial in patients with acute myeloid leukemia (AML), Celgene plans to pursue a…
    Read More…

    7 Jan
Close
Close
Close

Go Top